Polska - polski - URPL (Urząd Rejestracji Produktów Leczniczych, Wyrobów Medycznych i Produktów Biobójczych)

schuelke & mayr gmbh - alcohol isopropylicus + propanolum + 2-biphenylolum - roztwór na skórę - (8 g + 10 g + 2 g)/100 g

Polska - polski - Ministerstwo Rolnictwa i Rozwoju Wsi

basf se carl-bosch - strasse, 67056 ludwigshafen, niemcy - boskalid; metkonazol - metkonazol - 60 g, boskalid - 133 g - fungicyd

Polska - polski - Ministerstwo Rolnictwa i Rozwoju Wsi

madez- firma handlowo-usługowa mariusz rudnicki myśliborska, 74-240 lipiany - prochloraz - 450 g - fungicyd

Polska - polski - Ministerstwo Rolnictwa i Rozwoju Wsi

rudnikagro sp. z o.o. ul. pomorska, 70-812 - prochloraz - 450 g - fungicyd

Polska - polski - Ministerstwo Rolnictwa i Rozwoju Wsi

rudnikagro sp. z o.o. ul. pomorska, 70-812 - prochloraz - 450 g - fungicyd

Polska - polski - Ministerstwo Rolnictwa i Rozwoju Wsi

rudnikagro sp. z o.o. ul. pomorska, 70-812 - prochloraz - 450 g - fungicyd

Polska - polski - Ministerstwo Rolnictwa i Rozwoju Wsi

sharda cropchem españa s.l carril condomina, 30006 murcja - mezotrion - 360 g, nikosulfuron - 120 g, rimsulfuron - 30 g - chwastobójczy

Unia Europejska - polski - EMA (European Medicines Agency)

csl behring gmbh - ludzka normalna immunoglobulina (scig) - syndrom niedoborów immunologicznych - odporne surowicy i immunoglobuliny, - replacement therapy in adults, children and adolescents (0-18 years) in:- primary immunodeficiency syndromes with impaired antibody production (see section 4. - secondary immunodeficiencies (sid) in patients who suffer from severe or recurrent infections, ineffective antimicrobial treatment and either proven specific antibody failure (psaf)* or serum igg level of.

Unia Europejska - polski - EMA (European Medicines Agency)

ceva santé animale - inaktywowana szczepionka coxiella burnetii, szczep nine mile - immunologicals for bovidae, inactivated bacterial vaccines (including mycoplasma, toxoid and chlamydia) - goats; cattle - cattle: , for the active immunisation of cattle to lower the risk for non-infected animals vaccinated when non-pregnant to become shedder (5 times lower probability in comparison with animals receiving a placebo), and to reduce shedding of coxiella burnetii in these animals via milk and vaginal mucus. , onset of immunity: not established. , duration of immunity: 280 days after completion of the primary vaccination course. , goats: , for the active immunisation of goats to reduce abortion caused by coxiella burnetii and to reduce shedding of the organism via milk, vaginal mucus, faeces and placenta. , onset of immunity: not established. , duration of immunity: one year after completion of the primary vaccination course.

Unia Europejska - polski - EMA (European Medicines Agency)

novartis europharm limited - olamine - purpura, trombocytopenic, idiopatyczny - other systemic hemostatics, antihemorrhagics - revolade is indicated for the treatment of adult patients with primary immune thrombocytopenia (itp) who are refractory to other treatments (e. corticosteroids, immunoglobulins) (see sections 4. 2 i 5. revolade is indicated for the treatment of paediatric patients aged 1 year and above with primary immune thrombocytopenia (itp) lasting 6 months or longer from diagnosis and who are refractory to other treatments (e. corticosteroids, immunoglobulins) (see sections 4. 2 i 5. revolade is indicated in adult patients with chronic hepatitis c virus (hcv) infection for the treatment of thrombocytopenia, where the degree of thrombocytopenia is the main factor preventing the initiation or limiting the ability to maintain optimal interferon-based therapy (see sections 4. 4 and 5. revolade is indicated in adult patients with acquired severe aplastic anaemia (saa) who were either refractory to prior immunosuppressive therapy or heavily pretreated and are unsuitable for haematopoietic stem cell transplantation (see section 5.